Pediatric, Neonatal and Flextend Tracheostomy Tube Recall Issued

The FDA is warning that recalled Smiths Medical tracheostomy tubes could lead to severe injury or death due to problems disconnecting them from accessories. 

The Smiths Medical Bivona Neonatal, Pediatric and Flextend tracheostomy tubes recall was designated as a class 1 medical device recall on February 23, suggesting that the FDA believes the problems with the device are likely to cause serious injury or death.

Smith Medical originally sent out letters alerting its customers to problems with the tubes in late November.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Health care professionals have reported that it takes significant effort, and sometimes excessive force, to detach the tubes from accessories. The FDA warns that the amount of force used could dislodge the tracheostomy tube from the patient, which could lead to serious injury or death, especially if there is no replacement tube immediately available.

The FDA did not indicate whether there had been any injuries or deaths associated with the recall.

The recall affects Bivona Neonatal, Pediatric and Flextend Tracheostomy Tubes with the integrated connector that does not require use of a disconnect wedge. The affected tubes have lot numbers of 1631477 through 1923406. They were manufactured from August 29, 2009 through January 29, 2011.

The tubes are intended to provide airway access for a tracheostomized patient for up to a month and can be reused five times on a single patient. They are used in both health care facilities and in home care environments.

Smiths Medical has called for customers to identify and quarantine affected tubes, complete a confirmation form (pdf) and then fax or email that form back to the company. Their customer service will contact those customers and schedule replacements and returns.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted today)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.

Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL
Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL (Posted yesterday)

In advance of a a conference this week, lawyers report that progress is being made to prepare a group of federal Gardasil vaccine lawsuits for early test trials, to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation.

Enfamil Lawsuit Claims Preemie Developed NEC After Being Fed Cow's Milk-Based Infant Formula
Enfamil Lawsuit Claims Preemie Developed NEC After Being Fed Cow's Milk-Based Infant Formula (Posted 2 days ago)

Cow's milk-based infant formula products are dangerous for premature infants, according to a mother's recent Enfamil lawsuit, filed after her newborn developed necrotizing enterocolitis and suffered through surgery and continuing negative health effects.